Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum ...

Nijmegen, Netherlands Wednesday, April 23, 2025, 13:00 Hrs [IST] ...

Search for other works by this author on: ...

Cancer Res (2025) 85 (8_Supplement_1): 1126.

They're now using a similar approach to target avβ6 integrin, present in cancer tissues and wounds but not healthy tissues, using dimeric 'diabody' antibodies rather than scFvs. Figure 1 ...

Department of Chemical Engineering, Texas A&M University, College Station, Texas 77840, United States ...

和Diabody结构（两个scFv不与其自身的VL和VH相连，而是分别与对方的VH和VL相连）。 图2 双特异性抗体的三种主要结构 双特异性抗体的主要副产物 双 ...